Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Interstitial Cell Tumor

glucose, (beta-d)-isomer has been researched along with Interstitial Cell Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Jonghe, S; Feyen, B; Geys, H; Johnson, MD; Mamidi, RN; Marien, D; Proctor, J; Vinken, P; Wynant, I1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Interstitial Cell Tumor

ArticleYear
Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin.
    Chemico-biological interactions, 2014, Dec-05, Volume: 224

    Topics: Adrenal Gland Neoplasms; Animals; Canagliflozin; Carcinogenesis; Carcinogenicity Tests; Dose-Response Relationship, Drug; Glucosides; Kidney Neoplasms; Kidney Tubules; Leydig Cell Tumor; Male; Pheochromocytoma; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship; Testicular Neoplasms; Thiophenes

2014